The Recall Desk
SevereFDA (Devices)·Z-0882-2023·Announced 2023-01-18

Philips Trilogy 100 Ventilator Foam May Separate and Block Air Inlet

Silicone sound abatement foam in some Philips Trilogy 100 ventilators may separate and block the air inlet, potentially reducing delivered therapy volume or pressure and causing device alarms.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This is a Class I FDA recall, which mandates a minimum severity score of 4. Although no illnesses or injuries have been reported, the potential for failure in therapy delivery in ventilator-dependent patients represents a serious safety risk.

Plain-English summary

This is a Class I recall by the FDA concerning the Philips Trilogy 100 Ventilator, manufactured by Philips Respironics, Inc. Approximately 20,807 units are affected and have been distributed nationwide in the US and globally to Australia, Brazil, Canada, China, Germany, Japan, Korea, and Latin America.

The defect involves the replacement silicone sound abatement foam component. This foam may separate from the plastic backing to which it is attached. If separation occurs, the foam could potentially block the device's air inlet.

A blocked air inlet could result in a reduction of the therapy volume or pressure delivered to the patient and may cause the device to activate its alarm.

The recalled product

Product
Philips Trilogy 100 Ventilator, Model Numbers 1054260, 1054096, U1054260, U1054260B, 1054260B, CA1054096B, BT1054260, 1054096B, R1054260, RSL1054260, CA1054096, R1054260B, R1054655TPV, AU1054096, AU1054096B, 1054096B, 1054097, BR1054096, LA1054096, CN1054096, KO1054096, KR1054096
Manufacturer
Philips Respironics, Inc.
Hazard
  • foam-separation
  • inlet-blockage
  • therapy-loss

Distribution

Distributed nationwide across the United States.